C. Chouaïd

机构：Inserm, Université Paris-Est Créteil, Hôpital Intercommunal de Créteil, Institut Mondor de Recherche Biomédicale

发表论文 1040 篇 · 总被引 18547 次 · h-index 58

代表论文

Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration (2025 · JCO Oncology Practice · 被引 5)
Association of Sleep-Related Hypoxemia With Survival in Patients With Non-Small Cell Lung Cancer (2026 · CHEST Journal · 被引 1)
Figure 3 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study (2026)
Supplementary Figure S3 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study (2026)
Supplementary Figure S2 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study (2026)
Supplementary Table S1 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study (2026)